← Back to Search

Procedure

Comprehensive Aneurysm Management for Brain Aneurysms (CAM Trial)

N/A
Recruiting
Led By Tim Darsaut, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with at least one documented, intracranial subarachnoid aneurysm (cavernous aneurysms are excluded)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 5 and 10 years
Awards & highlights

CAM Trial Summary

This trial offers a comprehensive framework to address the clinical dilemma of UIAs, so that all patients confronted with the dilemma can be offered participation.

Who is the study for?
This trial is for patients with at least one documented brain aneurysm (excluding cavernous aneurysms). It's not for those who can't consent, have had a recent intracranial hemorrhage, or have aneurysms associated with arteriovenous malformation (AVM).Check my eligibility
What is being tested?
The study compares long-term outcomes of active treatment versus conservative management for unruptured brain aneurysms. It also evaluates whether microsurgery or endovascular interventions are more effective when surgery is necessary.See study design
What are the potential side effects?
Potential side effects include risks associated with brain surgery such as stroke, bleeding, infection and neurological deficits. Endovascular treatments may carry risks like vessel damage or clotting.

CAM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a documented brain aneurysm, but not in the cavernous part.

CAM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 5 and 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 5 and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neurologic Examination
Secondary outcome measures
Discharge location other than Home
Length of hospitalization
Overall morbidity
+3 more

CAM Trial Design

2Treatment groups
Active Control
Group I: Conservative ManagementActive Control1 Intervention
Monitoring with pharmacological therapy if need arises.
Group II: Interventional TherapyActive Control1 Intervention
Neurosurgery or Endovascular procedure

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
127,637 Total Patients Enrolled
University of AlbertaOTHER
889 Previous Clinical Trials
383,138 Total Patients Enrolled
Tim Darsaut, MDPrincipal InvestigatorNeurosurgeon University of Alberta Health
2 Previous Clinical Trials
2,015 Total Patients Enrolled

Media Library

Endovascular Interventions (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04155606 — N/A
Cerebral Aneurysm Research Study Groups: Conservative Management, Interventional Therapy
Cerebral Aneurysm Clinical Trial 2023: Endovascular Interventions Highlights & Side Effects. Trial Name: NCT04155606 — N/A
Endovascular Interventions (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04155606 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment available for this experiment at the present time?

"The data currently hosted on clinicaltrials.gov conveys that this trial is still open for candidates, and was originally posted on the 15th of January 2020 with its most recent revision taking place on May 31st 2022."

Answered by AI

How many participants are being given treatment within the scope of this clinical study?

"Affirmative. Clinicaltrials.gov has the most up-to-date information, which indicates that this trial is actively looking to recruit 2000 participants from 2 distinct medical locations. This clinical trial was initially posted on January 15th 2020 and was last updated on May 31st 2022."

Answered by AI

Who else is applying?

What site did they apply to?
University of Alberta Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Comprehensive Aneurysm Management Trial
Jean Raymond 2020. "Comprehensive Aneurysm Management Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04155606.
~1333 spots leftby Jan 2035
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top